Antibody to hepatitis E virus in HIV-infected individuals and AIDS patients

被引:43
作者
Balayan, MS
Fedorova, OE
Mikhailov, MI
Rytick, PG
Eremin, VF
Danilova, TI
Shevelev, BI
Gorbacheva, EC
Pankova, GY
机构
[1] RUSSIAN ACAD MED SCI, INST POLIOMYELITIS & VIRAL ENCEPHALITIS, MOSCOW 142782, RUSSIA
[2] NF GAMALEI INST EPIDEMIOL & MICROBIOL, MOSCOW, RUSSIA
[3] INST EPIDEMIOL & MICROBIOL, MINSK, BELARUS
[4] SECOND HOSP INFECT DIS, MOSCOW, RUSSIA
关键词
AIDS; antibody to hepatitis E virus; hepatitis E; HIV infection; seroprevalence;
D O I
10.1046/j.1365-2893.1997.00050.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Antibody to hepatitis E virus of IgG class (anti-HEV IgG) is regularly detected in industrialized countries, where HEV is non-endemic, at levels not exceeding 2-3%; seropositive individuals are often found in certain groups of patients and professionals exposed to an increased risk of blood-borne infections. The present study was aimed at the identification of anti-HEV IgG in patients with human immunodeficiency virus (HIV) infection, including acquired immune deficiency syndrome (AIDS), living in Russia and Belarus, an area of low anti-HEV prevalence with a moderate spread of HIV infection and AIDS. In Russia, 13 out of 117 HIV-infected patients (11.1%) were found to be anti-HEV seropositive. This differed significantly from the frequency observed in the normal population (1.7%) but not from the frequency in a matching control, high-risk group consisting of male prisoners (8.0%). No difference in the frequency of anti-HEV IgG seropositivity was found between groups of HIV-infected men subdivided by sexual orientation. The rate of anti-HEV seropositivity increased with the progression of HIV infection, reaching 43.3% in AIDS patients and 38.1% in those who died from AIDS. In Belarus, anti-HEV IgG seropositivity was not found among 20 HIV-infected subjects nor among individuals from the control risk group, which consisted of 25 intravenous drug users. In conclusion, HEV infection may have common transmission mechanisms (risk factors) with HIV infection rather than represent an additional opportunistic infection in AIDS.
引用
收藏
页码:279 / 283
页数:5
相关论文
共 20 条
[1]  
*ACQ IMM SYNDR AID, 1995, WHO WKLY EPIDEM REC, V70, P355
[2]  
*ACQ IMM SYNDR AID, 1996, WHO WKLY EPIDEM REC, V71, P361
[3]   Hepatitis E virus infection in patients from Saudi Arabia with sickle cell anaemia and beta-thalassemia major: Possible transmission by blood transfusion [J].
AlFawaz, I ;
AlRasheed, S ;
AlMugeiren, M ;
AlSalloum, A ;
AlSohaibani, M ;
Ramia, S .
JOURNAL OF VIRAL HEPATITIS, 1996, 3 (04) :203-205
[4]  
Balayan M S, 1994, Clin Diagn Virol, V2, P297, DOI 10.1016/0928-0197(94)90054-X
[5]  
Balayan M S, 1993, Clin Diagn Virol, V1, P1, DOI 10.1016/0928-0197(93)90027-3
[6]   Hepatitis E antibodies and HIV status [J].
Bissuel, F ;
Houhou, N ;
Leport, C ;
BrunVezinet, F ;
Vilde, JL .
LANCET, 1996, 347 (9013) :1494-1494
[7]   A high hepatitis E virus seroprevalence among renal transplantation and haemophilia patient populations [J].
Buffet, C ;
LaurentPuig, P ;
Chandot, S ;
Laurian, Y ;
Charpentier, B ;
Briantais, MJ ;
Dussaix, E .
JOURNAL OF HEPATOLOGY, 1996, 24 (01) :122-123
[8]   SOLID-PHASE ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR HEPATITIS-E VIRUS IGG AND IGM ANTIBODIES UTILIZING RECOMBINANT ANTIGENS AND SYNTHETIC PEPTIDES [J].
DAWSON, GJ ;
CHAU, KH ;
CABAL, CM ;
YARBOUGH, PO ;
REYES, GR ;
MUSHAHWAR, IK .
JOURNAL OF VIROLOGICAL METHODS, 1992, 38 (01) :175-186
[9]  
FEDOROVA OE, 1996, VOP VIRUSOL+, V3, P104
[10]   Hepatitis E virus infection in north-east Italy: Serological study in the open population and groups at risk [J].
Gessoni, G ;
Manoni, F .
JOURNAL OF VIRAL HEPATITIS, 1996, 3 (04) :197-202